Spleens of myelofibrosis patients contain malignant hematopoietic stem cells

Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition

(2012) Sonam Prakash et al.   MODERN PATHOLOGY

Differential Mechanical Response of Mesenchymal Stem Cells and Fibroblasts to Tumor-Secreted Soluble Factors

(2012) Daniel J. McGrail et al.   PLoS One

The mesenchymal tumor microenvironment

(2012) Edna Cukierman et al.   Cell Adhesion & Migration

Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease

(2011) R. M. Risueno et al.   BLOOD

Leukemic spleen cells are more potent than bone marrow-derived cells in a transgenic mouse model of CML

(2011) M Schemionek et al.   LEUKEMIA

Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells

(2010) X. Wang et al.   BLOOD

The splenomegaly of myeloproliferative and lymphoproliferative disorders: Splenic cellularity and vascularity

(2010) B. Zhang et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

(2010) Jean-Emmanuel Sarry et al.   JOURNAL OF CLINICAL INVESTIGATION

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

(2009) F. Passamonti et al.   BLOOD

Bone and Blood Vessels: The Hard and the Soft of Hematopoietic Stem Cell Niches

(2009) Russell W. Garrett et al.   Cell Stem Cell

How the niche regulates hematopoietic stem cells

(2009) Jonas Renström et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis

(2009) Ulrike Bacher et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms∗

(2009) Xiaoli Wang et al.   EXPERIMENTAL HEMATOLOGY

Hematopoietic niche and bone meet

(2009) Benjamin J Frisch et al.   Current Opinion in Supportive and Palliative Care

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

(2008) C. James et al.   BLOOD

Evolving concepts on the microenvironmental niche for hematopoietic stem cells

(2008) Marc HGP Raaijmakers et al.   CURRENT OPINION IN HEMATOLOGY

The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis

(2008) Juergen Thiele et al.   Current Hematologic Malignancy Reports

Mesenchymal stem cells from JAK2V617F mutant patients with primary myelofibrosis do not harbor JAK2 mutant allele

(2007) Lisa Pieri et al.   LEUKEMIA RESEARCH